[96a5a0]: / output / allTrials / logical / NCT03274882_logical.json

Download this file

747 lines (747 with data), 34.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
{
"info": {
"nct_id": "NCT03274882",
"official_title": "Open-label Multicentre Confirmatory Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Are Refractory or Intolerant to Standard Chemotherapies",
"inclusion_criteria": "* Male or female aged ≥18 years of age\n* Has definitive histologically or cytologically confirmed adenocarcinoma of the colon or rectum\n* Has received at least 2 prior regimens of standard chemotherapies for metastatic colorectal cancer (including fluoropyrimidines, irinotecan and oxaliplatin and, if accessible, an anti-VEGF monoclonal antibody and at least one of the anti-EGFR monoclonal antibodies for RAS wild-type patients (if RAS mutation status was evaluated)) and was refractory or intolerant to those chemotherapies\n* Has Eastern Cooperative Group (ECOG) performance status of 0 or 1\n* Has at least one measurable metastatic lesion(s)\n* Has adequate organ function\n* Female participants of childbearing potential and male participants with partners of childbearing potential must agree to use a highly effective method of birth control during the study and for 6 months after the discontinuation of study medication\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Pregnancy, breastfeeding\n* Participation in another interventional study within 4 weeks prior to inclusion; participation in non-interventional registries or epidemiological studies is allowed\n* Has previously received S95005 or history of allergic reaction attributed to compounds of similar composition to S95005\n* Has a serious illness or medical condition(s) as described in the protocol\n* Has had certain other recent treatment e.g. major surgery, field radiation, anticancer therapy, within the specified time frames prior to inclusion\n* Has unresolved toxicity of greater than or equal to Common Terminology Criteria for Adverse Events (CTCAE) Grade 2 attributed to any prior therapies.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Has at least one measurable metastatic lesion(s)",
"criterions": [
{
"exact_snippets": "at least one measurable metastatic lesion(s)",
"criterion": "metastatic lesion",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "N/A"
}
}
},
{
"exact_snippets": "at least one measurable metastatic lesion(s)",
"criterion": "metastatic lesion",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "at least one measurable metastatic lesion(s)",
"criterion": "metastatic lesion",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "N/A"
}
}
},
{
"exact_snippets": "at least one measurable metastatic lesion(s)",
"criterion": "metastatic lesion",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Has adequate organ function",
"criterions": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Female participants of childbearing potential and male participants with partners of childbearing potential must agree to use a highly effective method of birth control during the study and for 6 months after the discontinuation of study medication",
"criterions": [
{
"exact_snippets": "Female participants of childbearing potential",
"criterion": "female participants",
"requirement": {
"requirement_type": "childbearing potential",
"expected_value": true
}
},
{
"exact_snippets": "male participants with partners of childbearing potential",
"criterion": "male participants",
"requirement": {
"requirement_type": "partner's childbearing potential",
"expected_value": true
}
},
{
"exact_snippets": "must agree to use a highly effective method of birth control during the study and for 6 months after the discontinuation of study medication",
"criterion": "birth control",
"requirement": {
"requirement_type": "usage",
"expected_value": "highly effective method during the study and for 6 months after discontinuation"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "Female participants of childbearing potential",
"criterion": "female participants",
"requirement": {
"requirement_type": "childbearing potential",
"expected_value": true
}
},
{
"exact_snippets": "male participants with partners of childbearing potential",
"criterion": "male participants",
"requirement": {
"requirement_type": "partner's childbearing potential",
"expected_value": true
}
}
]
},
{
"exact_snippets": "must agree to use a highly effective method of birth control during the study and for 6 months after the discontinuation of study medication",
"criterion": "birth control",
"requirement": {
"requirement_type": "usage",
"expected_value": "highly effective method during the study and for 6 months after discontinuation"
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Pregnancy, breastfeeding",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Participation in another interventional study within 4 weeks prior to inclusion; participation in non-interventional registries or epidemiological studies is allowed",
"criterions": [
{
"exact_snippets": "Participation in another interventional study within 4 weeks prior to inclusion",
"criterion": "participation in another interventional study",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "participation in non-interventional registries or epidemiological studies is allowed",
"criterion": "participation in non-interventional registries or epidemiological studies",
"requirement": {
"requirement_type": "allowance",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"exact_snippets": "Participation in another interventional study within 4 weeks prior to inclusion",
"criterion": "participation in another interventional study",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
}
},
{
"exact_snippets": "participation in non-interventional registries or epidemiological studies is allowed",
"criterion": "participation in non-interventional registries or epidemiological studies",
"requirement": {
"requirement_type": "allowance",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Has previously received S95005 or history of allergic reaction attributed to compounds of similar composition to S95005",
"criterions": [
{
"exact_snippets": "Has previously received S95005",
"criterion": "previous treatment with S95005",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "history of allergic reaction attributed to compounds of similar composition to S95005",
"criterion": "allergic reaction to compounds similar to S95005",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Has previously received S95005",
"criterion": "previous treatment with S95005",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "history of allergic reaction attributed to compounds of similar composition to S95005",
"criterion": "allergic reaction to compounds similar to S95005",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Has a serious illness or medical condition(s) as described in the protocol",
"criterions": [
{
"exact_snippets": "Has a serious illness or medical condition(s)",
"criterion": "serious illness or medical condition",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Has a serious illness or medical condition(s)",
"criterion": "serious illness or medical condition",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Has had certain other recent treatment e.g. major surgery, field radiation, anticancer therapy, within the specified time frames prior to inclusion",
"criterions": [
{
"exact_snippets": "Has had certain other recent treatment e.g. major surgery",
"criterion": "recent major surgery",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Has had certain other recent treatment e.g. ... field radiation",
"criterion": "recent field radiation",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Has had certain other recent treatment e.g. ... anticancer therapy",
"criterion": "recent anticancer therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Has had certain other recent treatment e.g. major surgery",
"criterion": "recent major surgery",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Has had certain other recent treatment e.g. ... field radiation",
"criterion": "recent field radiation",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Has had certain other recent treatment e.g. ... anticancer therapy",
"criterion": "recent anticancer therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Has unresolved toxicity of greater than or equal to Common Terminology Criteria for Adverse Events (CTCAE) Grade 2 attributed to any prior therapies.",
"criterions": [
{
"exact_snippets": "unresolved toxicity ... greater than or equal to Common Terminology Criteria for Adverse Events (CTCAE) Grade 2",
"criterion": "unresolved toxicity",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "CTCAE Grade"
}
}
},
{
"exact_snippets": "attributed to any prior therapies",
"criterion": "attribution to prior therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "unresolved toxicity ... greater than or equal to Common Terminology Criteria for Adverse Events (CTCAE) Grade 2",
"criterion": "unresolved toxicity",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "CTCAE Grade"
}
}
},
{
"exact_snippets": "attributed to any prior therapies",
"criterion": "attribution to prior therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* Male or female aged ≥18 years of age",
"criterions": [
{
"exact_snippets": "Male or female",
"criterion": "gender",
"requirement": {
"requirement_type": "presence",
"expected_value": [
"male",
"female"
]
}
},
{
"exact_snippets": "aged ≥18 years of age",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "Male or female",
"criterion": "gender",
"requirement": {
"requirement_type": "presence",
"expected_value": "male"
}
},
{
"exact_snippets": "Male or female",
"criterion": "gender",
"requirement": {
"requirement_type": "presence",
"expected_value": "female"
}
}
]
},
{
"exact_snippets": "aged ≥18 years of age",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Has definitive histologically or cytologically confirmed adenocarcinoma of the colon or rectum",
"criterions": [
{
"exact_snippets": "definitive histologically or cytologically confirmed adenocarcinoma",
"criterion": "adenocarcinoma",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
},
{
"exact_snippets": "adenocarcinoma of the colon or rectum",
"criterion": "location of adenocarcinoma",
"requirement": {
"requirement_type": "location",
"expected_value": [
"colon",
"rectum"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "definitive histologically or cytologically confirmed adenocarcinoma",
"criterion": "adenocarcinoma",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"histologically"
]
}
},
{
"exact_snippets": "definitive histologically or cytologically confirmed adenocarcinoma",
"criterion": "adenocarcinoma",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"cytologically"
]
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "adenocarcinoma of the colon or rectum",
"criterion": "location of adenocarcinoma",
"requirement": {
"requirement_type": "location",
"expected_value": "colon"
}
},
{
"exact_snippets": "adenocarcinoma of the colon or rectum",
"criterion": "location of adenocarcinoma",
"requirement": {
"requirement_type": "location",
"expected_value": "rectum"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Has received at least 2 prior regimens of standard chemotherapies for metastatic colorectal cancer (including fluoropyrimidines, irinotecan and oxaliplatin and, if accessible, an anti-VEGF monoclonal antibody and at least one of the anti-EGFR monoclonal antibodies for RAS wild-type patients (if RAS mutation status was evaluated)) and was refractory or intolerant to those chemotherapies",
"criterions": [
{
"exact_snippets": "Has received at least 2 prior regimens of standard chemotherapies for metastatic colorectal cancer",
"criterion": "prior regimens of standard chemotherapies",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "regimens"
}
}
},
{
"exact_snippets": "including fluoropyrimidines, irinotecan and oxaliplatin",
"criterion": "types of chemotherapies received",
"requirement": {
"requirement_type": "presence",
"expected_value": [
"fluoropyrimidines",
"irinotecan",
"oxaliplatin"
]
}
},
{
"exact_snippets": "if accessible, an anti-VEGF monoclonal antibody",
"criterion": "anti-VEGF monoclonal antibody",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "at least one of the anti-EGFR monoclonal antibodies for RAS wild-type patients",
"criterion": "anti-EGFR monoclonal antibodies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "if RAS mutation status was evaluated",
"criterion": "RAS mutation status evaluation",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "was refractory or intolerant to those chemotherapies",
"criterion": "refractory or intolerant to chemotherapies",
"requirement": {
"requirement_type": "condition",
"expected_value": "refractory or intolerant"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Has Eastern Cooperative Group (ECOG) performance status of 0 or 1",
"criterions": [
{
"exact_snippets": "Has Eastern Cooperative Group (ECOG) performance status of 0 or 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Has Eastern Cooperative Group (ECOG) performance status of 0 or 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": "0"
}
},
{
"exact_snippets": "Has Eastern Cooperative Group (ECOG) performance status of 0 or 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": "1"
}
}
]
}
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}